Golden Heart Flower

Company Overview

Snapshot

Founded in May 2018 by Shlomi Schneider and Adi Moreh, Golden Heart Flower operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of disease-modifying medicines.

Business overview

Golden Heart Flower is an early-stage pharmaceutical company dedicated to developing novel approaches for treating rare diseases, specifically focusing on Glycogen Storage Diseases (GSDs) and Lysosomal Storage Diseases (LSDs). The company operates within the Health Tech & Life Sciences sector, with a core focus on Pharma & Medical Biotechnology and Drugs Discovery & Development, targeting the healthcare and life sciences markets.

Company Intelligence Q&A

What is Golden Heart Flower's primary focus?

Golden Heart Flower is primarily focused on developing disease-modifying medicines for rare conditions, including Glycogen Storage Diseases (GSDs) and Lysosomal Storage Diseases (LSDs).

When was Golden Heart Flower founded?

Golden Heart Flower was founded in May 2018.

Who are the founders of Golden Heart Flower?

Golden Heart Flower was co-founded by Shlomi Schneider and Adi Moreh.

What is the current employee size of Golden Heart Flower?

Golden Heart Flower currently has 1–10 employees.

In which sector does Golden Heart Flower primarily operate?

Golden Heart Flower operates in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology.